Toxicology Litigation Support

Vioxx®

VIOXX (rofecoxib) is a non-steroidal, anti-inflammatory drug referred to as a “COX-2 inhibitor” manufactured and marketed by Merck & Company. While Merck conducted major clinical trials on this drug, they were not forthright in disclosing the results which led to litigation related to cardiovascular and thrombotic events caused by Vioxx. The issue of causation is critical and meeting the causation criteria of the federal courts requires fulfilling the requirements of Daubert. Dr. Parent has written a causation report on Vioxx that has survived the Daubert challenge. More details on this drug may be found by clicking on the link indicated below.

• View Report